204 related articles for article (PubMed ID: 10221033)
1. Risk factors for the development of Escherichia coli O157:H7 associated with hemolytic uremic syndrome.
Kawamura N; Yamazaki T; Tamai H
Pediatr Int; 1999 Apr; 41(2):218-22. PubMed ID: 10221033
[TBL] [Abstract][Full Text] [Related]
2. Relative nephroprotection during Escherichia coli O157:H7 infections: association with intravenous volume expansion.
Ake JA; Jelacic S; Ciol MA; Watkins SL; Murray KF; Christie DL; Klein EJ; Tarr PI
Pediatrics; 2005 Jun; 115(6):e673-80. PubMed ID: 15930195
[TBL] [Abstract][Full Text] [Related]
3. Verocytotoxin-producing Escherichia coli infection in household members of children with hemolytic-uremic syndrome in The Netherlands.
Heuvelink AE; Van de Kar NC; Van Der Velden TJ; Chart H; Monnens LA
Pediatr Infect Dis J; 1999 Aug; 18(8):709-14. PubMed ID: 10462341
[TBL] [Abstract][Full Text] [Related]
4. The management of VTEC O157 infection.
Todd WT; Dundas S
Int J Food Microbiol; 2001 May; 66(1-2):103-10. PubMed ID: 11407539
[TBL] [Abstract][Full Text] [Related]
5. [Retrospective analysis of the relationship between HUS incidence and antibiotics among patients with Escherichia coli O157 enterocolitis in the Sakai outbreak].
Higami S; Nishimoto K; Kawamura T; Tsuruhara T; Isshiki G; Ookita A
Kansenshogaku Zasshi; 1998 Mar; 72(3):266-72. PubMed ID: 9643979
[TBL] [Abstract][Full Text] [Related]
6. Increased serum IL-10 and endothelin levels in hemolytic uremic syndrome caused by Escherichia coli O157.
Yamamoto T; Nagayama K; Satomura K; Honda T; Okada S
Nephron; 2000 Apr; 84(4):326-32. PubMed ID: 10754409
[TBL] [Abstract][Full Text] [Related]
7. Predictors for the development of haemolytic uraemic syndrome with Escherichia coli O157:H7 infections: with focus on the day of illness.
Ikeda K; Ida O; Kimoto K; Takatorige T; Nakanishi N; Tatara K
Epidemiol Infect; 2000 Jun; 124(3):343-9. PubMed ID: 10982057
[TBL] [Abstract][Full Text] [Related]
8. Does blood type B protect against haemolytic uraemic syndrome? An analysis of the 1996 Sakai outbreak of Escherichia coli O157:H7 (VTEC O157) infection. The Osaka HUS Critical Care Study Group.
Shimazu T; Shimaoka M; Sugimoto H; Taenaka N; Hasegawa T
J Infect; 2000 Jul; 41(1):45-9. PubMed ID: 10942639
[TBL] [Abstract][Full Text] [Related]
9. Predictors of hemolytic uremic syndrome in children during a large outbreak of Escherichia coli O157:H7 infections.
Bell BP; Griffin PM; Lozano P; Christie DL; Kobayashi JM; Tarr PI
Pediatrics; 1997 Jul; 100(1):E12. PubMed ID: 9200386
[TBL] [Abstract][Full Text] [Related]
10. Does levofloxacin induce hemolytic uremic syndrome in patients infected with verotoxin-producing Escherichia coli O157 infections?
Ohnishi K; Nakamura-Uchiyama F
Jpn J Infect Dis; 2012; 65(5):442-3. PubMed ID: 22996222
[TBL] [Abstract][Full Text] [Related]
11. Strength of the association between antibiotic use and hemolytic uremic syndrome following Escherichia coli O157:H7 infection varies with case definition.
Tarr GAM; Oltean HN; Phipps AI; Rabinowitz P; Tarr PI
Int J Med Microbiol; 2018 Oct; 308(7):921-926. PubMed ID: 30257808
[TBL] [Abstract][Full Text] [Related]
12. Hemolytic uremic syndrome following hemorrhagic colitis caused by verotoxin-producing Escherichia coli O157:H7: early signs of hemolytic uremic syndrome.
Tsuji A; Sasaki M; Kanemitsu T; Uehara N; Ito H; Honda M
Keio J Med; 1996 Mar; 45(1):44-7. PubMed ID: 8882467
[TBL] [Abstract][Full Text] [Related]
13. Inflammatory mediators in Escherichia coli O157:H7 hemorrhagic colitis and hemolytic-uremic syndrome.
Proulx F; Turgeon JP; Litalien C; Mariscalco MM; Robitaille P; Seidman E
Pediatr Infect Dis J; 1998 Oct; 17(10):899-904. PubMed ID: 9802632
[TBL] [Abstract][Full Text] [Related]
14. Risk of hemolytic uremic syndrome after antibiotic treatment of Escherichia coli O157:H7 enteritis: a meta-analysis.
Safdar N; Said A; Gangnon RE; Maki DG
JAMA; 2002 Aug; 288(8):996-1001. PubMed ID: 12190370
[TBL] [Abstract][Full Text] [Related]
15. Circulating granulocyte colony-stimulating factor, C-X-C, and C-C chemokines in children with Escherichia coli O157:H7 associated hemolytic uremic syndrome.
Proulx F; Toledano B; Phan V; Clermont MJ; Mariscalco MM; Seidman EG
Pediatr Res; 2002 Dec; 52(6):928-34. PubMed ID: 12438672
[TBL] [Abstract][Full Text] [Related]
16. Hemolytic-uremic syndrome associated with an infection by verotoxin producing Escherichia coli 0111 in a woman on oral contraceptives.
Stenger KO; Windler F; Karch H; von Wulffen H; Heesemann J
Clin Nephrol; 1988 Mar; 29(3):153-8. PubMed ID: 3282732
[TBL] [Abstract][Full Text] [Related]
17. Clinical experiences in Sakai City Hospital during the massive outbreak of enterohemorrhagic Escherichia coli O157 infections in Sakai City, 1996.
Fukushima H; Hashizume T; Morita Y; Tanaka J; Azuma K; Mizumoto Y; Kaneno M; Matsuura M; Konma K; Kitani T
Pediatr Int; 1999 Apr; 41(2):213-7. PubMed ID: 10221032
[TBL] [Abstract][Full Text] [Related]
18. Risk factors for the hemolytic uremic syndrome in children infected with Escherichia coli O157:H7: a multivariable analysis.
Wong CS; Mooney JC; Brandt JR; Staples AO; Jelacic S; Boster DR; Watkins SL; Tarr PI
Clin Infect Dis; 2012 Jul; 55(1):33-41. PubMed ID: 22431799
[TBL] [Abstract][Full Text] [Related]
19. Leukocytosis in children with Escherichia coli O157:H7 enteritis developing the hemolytic-uremic syndrome.
Buteau C; Proulx F; Chaibou M; Raymond D; Clermont MJ; Mariscalco MM; Lebel MH; Seidman E
Pediatr Infect Dis J; 2000 Jul; 19(7):642-7. PubMed ID: 10917223
[TBL] [Abstract][Full Text] [Related]
20. The association between idiopathic hemolytic uremic syndrome and infection by verotoxin-producing Escherichia coli.
Karmali MA; Petric M; Lim C; Fleming PC; Arbus GS; Lior H
J Infect Dis; 1985 May; 151(5):775-82. PubMed ID: 3886804
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
